Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)

NCT06859931 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: TQB3702 Tablets
DRUG: TQB3702 Tablets+TQB3702 Placebo
DRUG: TQB3702 Placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.